

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1233, 2000-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






Doxazosin cost effective for hypertension in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. :


Doxazosin cost effective for hypertension in diabetes
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :


Omapatrilat superior to enalapril in hypertension
Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. :